Upper limits of downstaging for hepatocellular carcinoma in liver transplantation

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Liver Transplantation 57%
• Patient 57%
• Milan Criteria 42%
• Biological Product 14%
• Transplantation 14%
• Neoplasm 14%
• Metastatic Carcinoma 14%
• Ablation Therapy 14%
• Patient Selection 14%
• Systemic Therapy 14%
• Alpha-Fetoprotein 14%
• Graft Survival 14%
• Transcatheter Arterial Chemoembolization 14%
• Disease Marker 14%
• Radioembolization 14%
• Therapeutic Procedure 14%
• Incidence 14%
• Organ 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Cell Carcinoma 100%
• Neoplasm 14%
• Biological Product 14%
• Metastasis 14%
• Disease Marker 14%
• Alpha Fetoprotein 14%
• Incidence 14%

Biochemistry, Genetics and Molecular Biology

• Tumor Volume 14%
• Alpha-Fetoprotein 14%
• Incidence 14%
• Reduction (Chemistry) 14%
• Survival 14%
• Aggressiveness 14%